Skip to main content

Table 1 CD133 and ALDH1 expression in liposarcoma patient samples.

From: Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential

Diagnosis Tumour site Age Pre-treatment Grade CD133 ALDH1
       Cytoplasm Nucleus
Well-diff. Retroperitoneal 36 No treatment 1 0 3 3
Well-diff. Retroperitoneal 57 No treatment 2 0 3 3
Myx/roundcell Thigh 41 No treatment 3 0 3 3
Myx/roundcell Thigh 79 Chemotherapy 4 0 3 3
De-diff. Thigh 79 No treatment 4 0 3 3
De-diff. Retroperitoneal 60 No treatment 4 0 1 1
Well-diff. Comp * Retroperitoneal 64 No treatment   0 3 3
De-diff. Comp* Retroperitoneal 64 No treatment 4 0 3 3
Pleomorphic Truncus 67 No treatment 4 0 3 3
Pleomorphic Retroperitoneal 58 No treatment 4 0 3 2
Well-diff. Leg 31 No treatment 1 0 2 2
  1. Ten liposarcomas diagnosed as well-differentiated (well-diff.), myxoid/roundcelled (myx/roundcell), de-differenitated (de-diff) or pleomorphic were included in the analyses. Tumour location, patient age, treatment prior to sample collection and tumour grade are also displayed. CD133 and ALDH1 expression was scored as follows: 0 = negative, 1 = less than 10% of the tumour cells scored positive, 2 = 10-50% of the rumour cells scored positive, 3 = more than 50% of the tumour cells scored positive. *For one of the tumors, a de-differentiated and a well-differentiated component was analysed.